Purpose: To report 2 cases with late postoperative Candida albicans interface keratitis and endophthalmitis after Descemet stripping automated endothelial keratoplasty (DSAEK) with corneal grafts originating from a single donor with a history of presumed pulmonary candidiasis.
I
nterface fungal keratitis and endophthalmitis is a rare, yet difficult to manage, complication of all types of lamellar keratoplasty. It typically presents in the late postoperative period as one or multiple infiltrates at the graft-host cornea interface in the deep stroma. This interface provides a unique sheltered environment for the development of infections and makes them particularly difficult to treat. The organisms are shielded in the interface from the normal anterior chamber immune defenses and from topical antifungals, which are notorious for their poor penetration in the deep corneal stroma. 1 It is believed that the causative fungus (Candida species in most cases) is introduced intraoperatively, and it comes either from the host flora or from the donor tissue. 2 Herein, we report 2 patients who developed Candida interface keratitis and endophthalmitis after Descemet stripping automated endothelial keratoplasty (DSAEK) with lenticules from the same donor.
CASE REPORTS Case 1
An 81-year-old man underwent uncomplicated DSAEK for pseudophakic bullous keratopathy 6 weeks before presentation at the Bascom Palmer Eye Institute. The donor rim culture was positive for Candida albicans at 7 days. The patient was administered a standard corticosteroid taper until his postoperative week 4 visit, at which time the outside surgeon noticed a few fluffy infiltrates at the graft-cornea interface. The patient was started on amphotericin B (5 mg/mL) 6 times a day and prednisolone acetate 1% 4 times a day. Two weeks later, the infiltrates appeared larger and there was anterior chamber reaction; thus, the patient was referred for further management.
His vision was count fingers; there was a hypopyon and multiple fluffy-appearing interface infiltrates (Fig. 1A ). An anterior chamber culture was taken, which grew C. albicans. Corticosteroids were stopped, and the patient received daily intracameral and intrastromal injection of amphotericin B (5 mg) and voriconazole (100 mg) for 2 days and was placed on hourly topical amphotericin B (5 mg/mL) and voriconazole (10 mg/mL). The clinical response was minimal; thus, the donor lenticule was explanted 1 day later, and the patient continued with daily intracameral and intrastromal antifungal injections and hourly topical antifungals. The donor lenticule also grew C. albicans sensitive to both amphotericin B and voriconazole. Three days after explantation of the donor lenticule, the stromal infiltrates were significantly worse (Fig. 1B) and signs of vitritis were noted on B scan ultrasound. Thus, therapeutic penetrating keratoplasty with a large diameter graft, intraoperative cryotherapy to peripheral infiltrates, iris biopsy, intraocular lens and capsule removal, and pars plana vitrectomy with injection of intravitreal amphotericin B (5 mg) and voriconazole (100 mg) at the end of the procedure were performed. The corneal and iris biopsies were positive for C. albicans, and the vitreous cultures were negative.
Intracameral injections of voriconazole (100 mg) were administered 2 to 3 times per week for the first postoperative month, and the patient was kept on topical amphotericin B (5 mg/mL) and voriconazole (10 mg/mL) for a total of 3 months. For the first 2 months postoperatively, a steroid-sparing immunosuppressive regimen was used with topical cyclosporine 0.05% every hour. Topical corticosteroids were then started with close follow-up. The therapeutic graft failed, and optical penetrating keratoplasty and glaucoma tube shunt implantation were performed after 6 months of clinical quiescence. His vision now (2 years later) corrects to 20/30+ with a rigid gas permeable lens (Fig. 1C) .
Case 2
A 67-year-old man underwent uncomplicated DSAEK for Fuchs endothelial dystrophy 1 day after patient 1 by a different surgeon and at a different surgery center. The donor rim culture was negative, but it was only kept for 4 days in the laboratory. The patient was doing well until 6 weeks postoperatively when the outside surgeon noticed interface infiltrates. An anterior chamber culture was taken, and it was positive for C. albicans. The patient was administered hourly amphotericin B (5 mg/mL) and was also administered topical corticosteroids 4 times a day. Two weeks later (ie, at 8 weeks postoperatively), his vision was count fingers; the infiltrates were worse and a hypopyon was also noted ( Fig. 2A) . Thus, the patient was referred to the Bascom Palmer Eye Institute for further management.
An anterior chamber culture was done on presentation, and it was positive for C. albicans. The patient received an intracameral and intrastromal injection of amphotericin B (5 mg) and voriconazole (100 mg), topical corticosteroids were stopped, and he was placed on hourly topical amphotericin B (5 mg/mL) and voriconazole (10 mg/mL). The donor lenticule was removed and also grew C. albicans sensitive to voriconazole and amphotericin B. Despite donor lenticule explantation and daily intracameral and intrastromal antifungal injections, the patient developed worsening infiltrates within the host cornea 1 week after explantation.
Therapeutic penetrating keratoplasty with a large diameter graft, intraoperative cryotherapy to peripheral infiltrates, iris biopsy, intraocular lens and capsule removal, and pars plana vitrectomy were performed with injection of intravitreal amphotericin B (5 mg) and voriconazole (100 mg) at the end of the procedure. C. albicans grew from the removed host cornea and was also seen on pathologic examination of the corneal button. Iris biopsy and vitreous cultures were negative for growth.
The patient received intracameral and intrastromal (at sites of previous peripheral infiltrates in the host) injections of amphotericin B (5 mg) and voriconazole (100 mg) 2 to 3 times per week for the first postoperative month. Serial anterior chamber cultures were negative postoperatively. He also used topical amphotericin B (5 mg/mL) and voriconazole (10 mg/mL) for the first 3 months as well as topical cyclosporine 0.5% 4 times a day. Topical corticosteroids were administered at the third postoperative month (prednisolone acetate 1% 3 times/d), and the patient was followed up closely for the first 6 months and remained free of recurrence. He now retains a clear graft, and his vision corrects to 20/20 with a rigid gas permeable lens at 2 years of follow-up (Fig. 2B) .
DISCUSSION
These 2 patients presented to us within 2 weeks after DSAEK 1 day apart, yet by different surgeons and at different surgical facilities. We contacted the eye bank that supplied the grafts to the 2 surgeons, and we were informed that both FIGURE 1. Slit-lamp photographs of patient 1 with post-DSAEK Candida albicans endophthalmitis. A, 81-year-old man with multifocal infiltrates at the graft-host cornea interface and hypopyon 6 weeks after uncomplicated DSAEK. The donor rim culture was positive for C. albicans at 7 days. B, Three days after donor lenticule removal, intensive topical amphotericin B (5 mg/mL) and voriconazole (10 mg/mL), and daily intracameral and intrastromal injections of amphotericin B (5 mg) and voriconazole (100 mg), the infiltrates within the host cornea are significantly larger in size. The patient underwent therapeutic penetrating keratoplasty, intraocular lens and capsule removal, and pars plana vitrectomy. C, The large therapeutic graft failed, and optical penetrating keratoplasty and glaucoma tube shunt implantation were performed 6 months later. At 2 years of follow-up, the patient refracts to 20/30+ with a rigid gas permeable lens.
grafts originated from the same donor. The donor was a 63-year-old man who died of respiratory failure after short hospitalization. He had chronic bronchitis, and a family member reported a history of "pulmonary candidiasis." There were no positive blood cultures during his hospitalization and no documentation of sepsis. Whole-genome sequencing revealed genetically identical strains of C. albicans from the donor lenticules of both patients.
Both tissues were precut at the eye bank. The death-topreservation time was 7 hours 8 minutes, and the storage medium used was Optisol GS. The tissue was in the storage medium for 6 days (patient 2) or 7 days (patient 1) before transplantation. For patient 1, the postcut endothelial cell count was 2907, and the graft tissue thickness was 111 mm. For patient 2, the postcut endothelial cell count was 2817, and the graft tissue thickness was 119 mm. No venting incisions were used by either surgeon during surgery. For patient 1, the surgeon used a tissue folding technique to insert the tissue into the anterior chamber. For patient 2, the surgeon used the Tan injector.
In these 2 cases, initial treatment with topical, intracameral, and intrastromal antifungals alone was not successful, nor was removal of the donor lenticule. In fact, the infection worsened after lenticule removal perhaps due to liberation of the sequestered fungi. Penetrating keratoplasty along with intraocular lens explantation, capsular bag removal, pars plana vitrectomy, and intravitreal antifungals was required to achieve control of the infection and save these eyes.
Review of all the reported cases of fungal interface keratitis shows that almost all failed topical and/or systemic antifungal therapy (see Table, Supplemental Digital Content 1, http://links.lww.com/ICO/A546). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Only 3 of 21 reported cases of post-DSAEK fungal keratitis resolved with intrastromal, topical, and oral antifungals. 1, 12 Removal of the donor lenticule along with topical, intracameral, and oral antifungals was performed in 9 of 21 cases, 2,5,6,8,9,14 but was successful in eradicating the infection in only 3 of those 9 eyes. 8, 9, 14 The other 6 of those 9 eyes underwent therapeutic penetrating keratoplasty due to the presence of fungal infiltrates in the host corneal stroma after donor lenticule removal. 2, 5, 6 Except for one case of interface keratitis due to Aspergillus fumigatus, 7 all other reported cases were caused by Candida species (12 by C. albicans, 3 by Candida parapsilosis, 1 by Candida glabrata, and 2 by yeast identified on confocal microscopy). Obtaining an adequate sample of a DSAEK-interface infiltrate for proper microbiological testing is challenging, and penetration of topical antifungals may not be sufficient to adequately treat the infection. Our review of the literature and our experience with these 2 cases suggest that perhaps therapeutic penetrating keratoplasty should be performed early in cases of interface fungal keratitis due to the generally poor response to medical treatment or graft lenticule removal.
We should note that in our 2 cases, one rim culture was positive for C. albicans, whereas the other was not, but it was kept only for 4 days. Fungal organisms can take longer to grow in vitro, and depending on the size of the inoculum they may not grow at all. Donor rim cultures were done in 18 of the 21 cases in the literature; they were positive in 8 of them (44%), negative in 8 of them (44%), and not reported (likely negative) in 2 (11%) of the 18 cases (see Table, Supplemental Digital Content 1, http://links.lww.com/ICO/A546). The duration of incubation of the rim culture in the microbiology laboratory is not reported. In all 8 cases with a positive rim culture, the organism that grew was identical to the one causing the interface infection (C. albicans in all 7 cases and C. glabrata in 1 case). 4, 9, [12] [13] [14] This highlights the importance not only of performing donor rim cultures in every case but also of keeping the culture long enough for a potentially fastidious organism to grow.
A high suspicion for a postoperative fungal interface keratitis should be maintained, especially in the setting of a positive donor rim culture. Corneal storage media in the United States are not supplemented with antifungals, and a small inoculum may lead to an infiltrate in the protected environment of the graft-host interface. Moreover, small interface infiltrates may be misdiagnosed as debris, and may take weeks or months to blossom. This is due to the slow growth of fungi and the routine use of postoperative steroids. Thus, an interface infiltrate that appears several weeks after endothelial transplantation should raise our suspicion for a fungal infection. FIGURE 2. Slit-lamp photographs of patient 2 with post-DSAEK Candida albicans endophthalmitis with graft originating from the same donor as patient 1. A, 67-year-old man with fluffy-appearing infiltrates at the graft-host cornea interface and hypopyon 8 weeks after routine DSAEK for corneal edema due to Fuchs endothelial dystrophy. The donor rim culture was negative at 4 days, and the anterior chamber culture grew the same genetic strain of C. albicans as patient 1. Immediate donor lenticule removal and daily intracameral and intrastromal injections of amphotericin B (5 mg) and voriconazole (100 mg) failed to control the infection. A therapeutic graft, cryotherapy to the peripheral infiltrates, explantation of the intraocular lens, and pars plana vitrectomy were performed. B, The graft remains clear at 2 years of follow-up, and the patient refracts to 20/20 with a rigid gas permeable lens.
Finally, once a postkeratoplasty patient is diagnosed with fungal keratitis, the recipient of the donor mate should also be followed up closely. According to the most recent Eye Bank Association of America medical advisory report in 2013, if a cornea from a donor harbors a fungal burden sufficient to cause a postkeratoplasty fungal infection in a recipient eye, the other cornea from the same donor will very likely (67% of the time) cause a fungal infection in the second recipient. 15 Therefore, surgeons ought to report to the supplying eye bank such postoperative complications early as they can be sight saving for the second recipient.
